Pharmacological basis of the anti-VEGF therapy

Leopold Schmetterer; Gerhard Garhöfer

doi:10.1007/s00717-012-0110-0

Pharmacological basis of the anti-VEGF therapy

Leopold Schmetterer^*, Gerhard Garhöfer

^*Corresponding author for this work

Medical University of Vienna

Research output: Contribution to journal › Review article › peer-review

Abstract

Summary: This review seeks to summarize our current knowledge on the pharmacological basis of the different currently available anti-VEGF treatments. In addition, results of major clinical trials and the potential differences between the different treatment approaches will be covered.

Original language	English
Pages (from-to)	185-196
Number of pages	12
Journal	Spektrum der Augenheilkunde
Volume	26
Issue number	4
DOIs	https://doi.org/10.1007/s00717-012-0110-0
Publication status	Published - Oct 2012
Externally published	Yes

ASJC Scopus Subject Areas

Ophthalmology

Keywords

Age related macular degeneration
Vascular endothelial growth factor

Access to Document

10.1007/s00717-012-0110-0

Cite this

@article{7576841867fe46f38b47dfd733463391,

title = "Pharmacological basis of the anti-VEGF therapy",

abstract = "Summary: This review seeks to summarize our current knowledge on the pharmacological basis of the different currently available anti-VEGF treatments. In addition, results of major clinical trials and the potential differences between the different treatment approaches will be covered.",

keywords = "Age related macular degeneration, Vascular endothelial growth factor",

author = "Leopold Schmetterer and Gerhard Garh{\"o}fer",

year = "2012",

month = oct,

doi = "10.1007/s00717-012-0110-0",

language = "English",

volume = "26",

pages = "185--196",

journal = "Spektrum der Augenheilkunde",

issn = "0930-4282",

publisher = "Springer Wien",

number = "4",

}

TY - JOUR

T1 - Pharmacological basis of the anti-VEGF therapy

AU - Schmetterer, Leopold

AU - Garhöfer, Gerhard

PY - 2012/10

Y1 - 2012/10

N2 - Summary: This review seeks to summarize our current knowledge on the pharmacological basis of the different currently available anti-VEGF treatments. In addition, results of major clinical trials and the potential differences between the different treatment approaches will be covered.

AB - Summary: This review seeks to summarize our current knowledge on the pharmacological basis of the different currently available anti-VEGF treatments. In addition, results of major clinical trials and the potential differences between the different treatment approaches will be covered.

KW - Age related macular degeneration

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84867667435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867667435&partnerID=8YFLogxK

U2 - 10.1007/s00717-012-0110-0

DO - 10.1007/s00717-012-0110-0

M3 - Review article

AN - SCOPUS:84867667435

SN - 0930-4282

VL - 26

SP - 185

EP - 196

JO - Spektrum der Augenheilkunde

JF - Spektrum der Augenheilkunde

IS - 4

ER -

Pharmacological basis of the anti-VEGF therapy

Abstract

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this